Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,950.00
(
0.90%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,320.56
(
0.16%
)
News Focus
News Focus
Post# of 80490
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Whosetosay

Send PM Follow Ignore
Followers 26
Posts 4429
Boards Moderated 0
Alias Born 06/08/2010

Whosetosay

Re: None

Saturday, 10/15/2016 7:49:31 AM

Saturday, October 15, 2016 7:49:31 AM

Post# of 80490
BTW, I had advised a much higher price than $200,000. I advised $275,000.

The $275,000 level is comparable (less costly actually) to pricing for Alexion’s drug Soliris which addresses a larger patient population than Iclusig.

The BoD overpaid themselves and the CEO, they breached their fiduciary responsibilities, they doctored their records and coerced and bought off their accuser...I want THE TRUTH!!!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today